Pfizer RSV vaccine for infants has ‘generally favorable’ safety data, FDA staff say
The FDA is slated to make a decision on whether to approve Pfizer’s shot in August before respiratory syncytial virus season in the fall.
White House to invest nearly $11 billion for renewable energy in rural areas
Rural electric cooperatives, renewable energy firms and electric utilities can apply for funding through two programs under Biden’s Inflation Reduction Act.
Cosmic Aerospace is working on an electric plane with real range
The aim is to build an electric plane that operates without any emissions but that can still fly for just over 600 miles
Morgan Stanley reinstates coverage of this controversial used-car play
The firm resumed coverage of Carvana, citing “improved confidence.” The stock could see a wide range of outcomes from here, analyst Adam Jonas said.
Stashing cash: 71% of Americans are setting more money aside amid recession fears, new report finds
Depending on how accessible you need your savings to be, here are some of the best ways to earn interest on your emergency money.
Homebuilder sentiment pulls out of negative territory for the first time in nearly a year
It’s the fifth straight month of gains and the first reading of builder sentiment since July that wasn’t negative.
Retail sales rose 0.4% in April, less than expected as consumers struggle with inflation
Excluding auto-related figures, sales increased 0.4%, which was in line with expectations.
OpenAI CEO Sam Altman testifies before U.S. Senate: live
OpenAI CEO Sam Altman is testifying before the U.S. Senate Judiciary Committee on AI oversight and regulation. Watch live here.
Sam Altman wows lawmakers at closed AI dinner: ‘Fantastic…forthcoming’
Lawmakers had a dinner discussion with OpenAI CEO Sam Altman. It comes at a peak moment for AI, which has thoroughly captured Congress’ fascination.
FTC sues to block Amgen acquisition of Horizon Therapeutics
Amgen wants to buy Horizon Therapeutics to bolster is drug portfolio as it faces patent expirations. The FTC fears the deal could entrench monopoly positions.
